12:25 PM EST, 11/10/2025 (MT Newswires) -- Codexis ( CDXS ) said Monday it signed a lease for a 34,000-square-foot GMP manufacturing facility in Hayward, California.

The facility will allow Codexis ( CDXS ) to broaden its internal capabilities to manufacture siRNA and other oligonucleotides using its ECO Synthesis platform, the company said.

Codexis ( CDXS ) said it expects to start modifications to the existing facility in early 2026.

Price: 1.70, Change: +0.01, Percent Change: +0.59